Abstract
DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL TO ASSESS THE EFFICACY OF INTRAVENOUS GAMMAGLOB-ULIN FOR THE MANAGEMENT OF CHRONIC FATIGUE SYNDROME IN ADOLESCENTS. Rowe K. S. J Psychiatr Res 1997; 31(1): 133-47.
AN OPEN STUDY OF THE EFFICACY AND ADVERSE EFFECTS OF MOCLOBEMIDE IN PATIENTS WITH THE CHRONIC FATIGUE SYNDROME. White P. D., K. J. Cleary. Int Clin Psychopharmacol 1997; 12(1): 47-52.
RANDOMISED CONTROLLED TRIAL OF GRADED EXERCISE IN PATIENTS WITH THE CHRONIC FATIGUE SYNDROME. Fulcher K. Y., P. D. White. BMJ 1997; 314(7095): 1647-52.
COGNITIVE BEHAVIOR THERAPY FOR CHRONIC FATIGUE SYNDROME: A RANDOMIZED CONTROLLED TRIAL. Deale A., S. Wessely, I. Marks, T. Chalder. Am JPsychiatry 1997; 154(3): 408-14.
INTRAVENOUS 1MMUNOGLOBULIN IS INEFFECTIVE G? THE TREATMENT OF PATIENTS WITH CHRONIC FATIGUE SYNDROME. Vollmer-Conna U, A. Lloyd, J. Dwyer, D. Wakefield, K. Tymms, D. Hadzi-Pavlovic, I. Hickie. Am J Meet 1997; 103(1): 38-43.
AMANTADINE AND L-CARNITINE TREATMENT OF CHRONIC FATIGUE SYNDROME. Plioplys A. V., S. Plioplys. Neuropsv-chobiology 1997; 35(1): 16-23.